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The aim of this work was the investigation of the biotransformation ability of a
synthetic benzofurane typeg-lactone.Thisworkwasbasedon themicrobiological reactions
of Aspergillus niger, Saccharomyces cerevisiae, Bacillus mycoides, Agrobacterium tumefa-
ciens,PseudomonasglicineaandPseudomonas fluorescens toobtainnewactivederivatives.
Four biotransformation products were determined. The lactone was used for two purposes,
as an additive for the nutrient substrate and as a source of organic carbon.
Keywords: synthesis, g-lactone, biotransformation, d-lactone.
Thephysiological activity of lactones ofnatural originhas beenknownever since
santonin was used as an important antihelminatic and ascaricidol agent. Owing to their
high level of physiological activity, natural and synthetic lactones have been the subject
of biochemical investigations as potential therapeutic agents since 1970.1-3
From the chemical point of view, the potential cytotoxic activity of many
sesquiterpene lactones of plant origin is based on their ability to selectively inhibit
certain enzyme systems. The numerous results published so far prove that the
presence of the O=CC=CH
2
system in the molecule4-6 is directly responsible for
the cytotoxic activities of observed compounds.
The physiological activity of a lactone increases with the presence of more
than one unsaturated ester or epoxide group in the five-membered and six-mem-
bered ring molecule. It has also been demonstrated that synthetic a-methylene
butyrolactone derivatives containing no other reactive functional group can have
growth inhibition activity comparable to that of multifunctional products.7-10
The results published in this field, to date, have opened the way to the
formulation of new synthetic methods for obtaining lactone, a-methylene butyrolac-
tone and similar functional compounds which exhibit some therapeutic effects as
growth inhibitors in cultures ofCCRF-CEMhuman lymphoblastic leukemia cells.11,12
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Our investigations of the biotransformation of lactones was started with
microorganisms because of several favorable aspects: the short vegetation period,
the ability of the enzyme system to adapt to altered development conditions and the
possibility of developing selective methods for obtaining new active compounds or
for the synthesis of precursors of new biologically active compounds.
The microorganisms developed in the nutrient substrate inter alia containing
lactone as well as in substrates in which lactone was used as the source of organic
carbon.
The investigation of extracellular samples demonstrated the ability of the
tested fungi and bacteria to biotransform synthetic lactones, and depending on the
chemical structure of biotransformation products, evidenced the biodegradation
mechanisms of the lacones.13
Chemical Assay
In our laboratory the chemical synthesis of a biologically active benzofuran
type lactone with a new structure, an a-methylene butyrolactone, was achieved. The
chemical transformation of 4-dichloromethyl-4-methyl-5-(dimethoxycarbonyl) me-
thylene-2-cyclohexenone (1) in the synthesis of several polyfunctional products with
the g-lactone ring was also reported.
The most direct route to a g-lactone seems to be acetoxylation,15 oxidation14
and cyclisation of 4-dichloromethyl-4-methyl-5-methylenecarboxy-1-cyclohexen-
one (2) (Scheme1)with lead(IV) acetatewhich results in awhite crystalline product,
Scheme 1
i. CH2 (COOCH3)2 CH3OH, NA iii. Pb(OAc)4 BF3-Et2O
ii. HCl 1:1 iv. HCOOEt, NaH, HCHo
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containing only the g-lactone trans-3H, 3aH, 7aH-4-methyl-4-dichloromethyl-2,7-
benzofuranione (3) in a yield of 7580%.
The g-lactone derivative16,17 3 was formylated by the standard technique to
give the sodium salt of the a-formyl g-lactone (not-isolated) in 65.5% yield.
Subsequent refluxing with formaldehyde gave white crystals in 56% yield.
The structure of the obtained compounds were characterized by their physical
and chemical constants, 1H-NMR and IR spectra.
Bioassay
The investigation encompassed the biotransformation reactions of the lac-
tones when the lactone was used as a component in the nutrient substrate in the
concentration of 2 mg on 10 mL of fermentation solution with the following
microorganisms: B. mycoides, A. tumefaciens, A. niger and S. cerevisiae.
The microorganisms B. mycoides, A. tumefaciens, P. glicinea and P. fluores-
cens were used to investigate the lactone biotransformation mechanisms when the
lactone was used as a source of organic carbon, which was achieved by exchanging
the standard nutrient substrate with a mineral substrate.
RESULTS ANDDISCUSSION
The ability of A. niger and S. cerevisiae fungi as well as A. tumefaciens and
B. mycoides to transform the lactone, when it was used as a constituent element of
nutrient substrate, was investigated in the first series of experiments.
The investigations were performed over 5 days according to the microorgan-
ism inoculation and the obtained results pertaining to the extracellular part of the
investigation for the individual microbiological species are presented in Table I.
TABLE I. Comparative values for the starting lactone and valuable lactone products in investigated
samples
Culture
Rf value of the
starting lactone
Rf values of the
biotransformation products
Total amount of
lactone [mg]
A. niger 0.24 0.09, 0.36, 0.43 200
S. cerevisiae 0.24  200
B. mycoides 0.24 0.09, 0.42 200
A. tumefaciens 0.24  200
S. cerevisiae completely degrades the lactone to organic compounds with
small biomass and includes them in their metabolic process. The A. niger fungi
degrade the lactone at a slower rate, which enabled the identification of three
transformation products Rf = 0.09 Rf = 0.36 and Rf = 0.42.
The result obtained for the metabolic parameters of the tested samples, with
bacteria cultivation, compared with those registered for standards, enabled the
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following conclusions to be drawn: B. mycoides degrade the lactone at a slow rate,
which enabled the identification of two transformation productsR
f
= 0.09, andR
f
= 0.42.
Within five days, A. tumefaciens bacteria completely degraded the lactone,
but no lactone and no products of its biotransformation could be identified.
The obtained experimental results demonstrate the essential influence of the
lactone on the metabolism of the bacteria. In addition to the investigation of A.
tumefaciens and with lactone as the source of organic carbon, two more microor-
ganisms Pseudomonas glicinea and Pseudomonas fluorescenswere introduced into
the second series of experiments.
The lactone was added to the mineral nutrient substrate in concentrations of
1 mg/mL and 7 mg/mL. The development of microorganisms was interrupted after
five days, and the samples thus obtained were treated in the same way as in the first
series of investigations. The results obtained are presented in Table II.
TABLE II. Lactone degradation products in the samples in which the lactone was used as a source of
carbon
Culture Lactone [C]/mg Rf value of the
starting lactone
Rf values of the
degradation products
Total amount of
lactone [mg]
A. tumefaciens 1/7 0.24 0.43 200
B. mycoides 1/7 0.24 0.10, 0.44 200
P. glicinea 1 0.24 0.17, 0.45, 0.83, 0.86 200
7
0.17, 0.44, 0.78,
0.87, 0.92
200
P. fluorescens 1/7 0.24 -0.17, 0.45 200
Finally, based on the presented results, is can be concluded:
Both species S. cerevisiae and A. niger degrade the lactone but at different
rates, the degradation being slower in the case of A. niger.
The investigation using the lactone as a source of organic carbon for the P.
glicinea, A. tumefaciens, B. mycoides andP. fluorescens bacteria yielded the following
conclusion. All four species use lactone as a source of organic carbon but the rate and
the effect of the degradation depend on the structure of the group and on the lactone
concentration.
The lactone biotransformation mechanism also depends on the microbiologi-
cal species being almost identical for A. tumefaciens s, B. mycoides and P. fluores-
cens but different for P. glicinea. (Scheme 2).
EXPERIMENTAL
General
Melting points were recorded on a Kofler-hot stage apparatus and are uncorrected. Microana-
lysis of carbon and hydrogen was carried out with a Carlo Erba 1106 microanalyser. The IR spectra
were run on a Perkin-Elmer Grating Spectrophotometer either Model 137 or Model 197. The NMR
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spectra were recorded on a VARIAN FT 80A a 200 "Gemini" Spectrometer (
1
H at 80 and 200 MHz,
13
C
at 25MHz and 80MHz); CDCl3, usingTMS as the internal standard. Chemical shifts are given ind(ppm),
couplingconstantsJ inHz.Abbreviations:s-singlet,d-doublet, t-triplet,q-quartet,m-multiplets andb-broad.
The Mass spectroscopic analyses were carried out on a Finnigen MAT 8230 spectrometer. Abbreviations
used:LTA-Lead tetraacetate, TLC-thin layer chromatography,THF-tetrahydrofuran.The preparative layer
chromatography was carried out usingMerck Kieselgel 60 PF254+366.
4-Dichloromethyl-4-methyl-5-(dimethoxycarbonyl)methylene-2-cyclohexenone (1)
A solution of 945 mg of the ketone 4-dichloromethyl-4-methyl-2,5-cyclohexa-dienone, 660
mg dimethyl malonate, and sodium methoxide (from 115 mg of sodium in 15 mLmethanol) was kept
under nitrogen at room temperature for 2 h. The yellow solution was evaporated under vacuum and
ether was added. The resultant suspension was filtered and the precipitate was washed with ether.
Evaporation of the combined filtrate and washing and crystallization of the solid residue yielded 350
mg of starting ketone. The precipitate was dissolved in the minimal amount of water, saturated with
carbon dioxide and the solution was extracted with chloroform. The extract was dried over anhydrous
sodium sulfate and evaporated. Crystallization of the solid residue, 540 mg, (34.5%), from ether gave
the ester, m.p. 108109 ºC. Spectral data according to the literature.
19,20
4-Methyl-4-dichloromethyl-5-methylenecarboxy-2-cyclohexenone (2)
A mixture of 100 mg of ester and 5 mL of 50% hydrochloric acid was refluxed for 4h. The
cooled suspension was filtered. The filrate was extracted with chloroform, and the extract was dried
and evaporated. Crystalliziation from ether of the combined residue and the previous precipitate
yielded a total of 65 mg (96%) of 2 m.p. 185 ºC.
IR (KBr): n(cm
-1
) 34502570 (OH), 1725 (C=O acid), 1705 (C=O, enone).
1
H-NMR (CDCl3. d)
1.35 (s, 3H, CH3), 6.51 (s, H, CHCl), 6.05 (d, H, J = 10.2 Hz), 7.04 (d, H, J = 10.2 Hz), m.p. 185  186 ºC,
yield 96%. Anal. calc. for C10H12O3Cl2 (251.109): C, 47.81; H, 4.82. Required: C, 47.96; H, 4.85
Scheme 2. Biotransformation of lactone
I= A.niger. P.glicinea
II= A.niger. B.mycoides P.tumefacions. P.fluorescens
III= A.niger. B.mycoides P.fluorescens
IV= P.glicinea.
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trans-3H,3aH, 7aH-4-Dichloromethyl-4-methyl-2,7-benzofurandione (3)
To a suspension of LTA(1.2 mmol) in cold benzene (20mL) and borontriforide etherate (5 cm),
a solution of compound 1 (590 mg, 1.2 mmol) in benzene was added over 5 h at room temperature.
The reaction mixture was then poured into cold water (150 mL) and the solution obtained was filtered
over cellite 577. The organic layer was separated from the aqueous layer, extracted with a saturated
solution of sodium bicarbonate and sodium chloride, and then dried with anhydrous sodium sulfate.
Evaporation of the solvent afforded an oil, which crystallized out from ether.
IR (KBr), n(cm
-1
): 1785 (C=O), lactone), 1695 (C=CC=O), 1180 (CO), 810, 790, (CCl).
1
H-NMR (CDCl3, d): 1.41 (s, 3H, CH3), 2.51 (ABq. 2H, C-3, 2J = 14.71 Hz, 3J=8.06 Hz, 3J=12.54
Hz), 3.51 (m, H, C-3a,
3
J=8.06 Hz,
3
J=12.54 Hz,
3
J=7.73 Hz,
4
J=1.79 Hz), 5.14 (d, 1H, C-7a,
3
J=7.73
Hz), 5.79 (s, 1H, CHCl2), 6.31 (d, H, C-6,
3
J=10.31 Hz), 6.75 (dd 1H, C-5,
3
J=10.31 Hz,
4
J=1.79 Hz).
13
C-NMR, ppm: 173.54 (C-2), 43.27 (C-3), 29.67 (C-3a), 44.38 (C-4), 150.29 (C-5), 129.8 (C-6),
195.54 (C-7), 80.33 (C-7a), 18.98 (CH3), 79.76 (CHCl2); m.p. 118 ºC, yield 71%. Anal. calc. for
C10H10O3Cl2 (249.092): C, 48.19; H, 4.02. Required: C, 48.56; H, 4.07.
trans-3H,3aH, 7aH-4-Dichloromethyl-4-methyl-3-methylyliden-2,7-benzofurandione (4)
Asodium hydride dispersion in mineral oil (57%, 4.4 g 0.105 mol) was placed in a dry 250 mL
three-necked flask to which an additional funnel and mechanical stirrer were attached and washed
three timeswith dry hexane and then suspended in diethyl ether (100mL, freshly distilled fromLiAlH4)
under nitrogen. Amixture of the g-lactone (2.5 g. 0.01 mol) and ethyl formate (0.74 g. 0.01 mol dried
over K2CO3 and distilled from P2O5) was slowly added to the stirred suspension, immediately
following the addition of absolute ethanol (0.5 mL), at a rate that maintained a gentle reflux of the
reaction solvent. After stirring overnight the reaction mixture was rapidly filtered by suction and the
resulting solid was washed well with dry diethyl ether and dried under vacuum, which produced the
sodium salt of the a-formyl g-lactone in the form of a light tan powder (1.95 g, 65.5%). The sodium
salt of the formyl g-lactone (1.45 g, 0.05 mol) and formaldehyde (200 mg, 0.085 mol) were refluxed
in THF as solvent, the latter had been refluxed under nitrogen for a period of 4 h. The suspension
containing the a-methylene g-lactone was filtered through a large media frit, and the solvent was
removed under reduced pressure. The crude reaction products were purified by passage through a 20.0
cm. Silica gel pad using dichloromethane as the solvent. The substituted methylene lactone was
repurified by remowal of the solvent under reducedpressure, the addition of 10mLof 6Mhydrochloric
acid, and by extraction three times with 15 mL ethyl ether. The combined previously obtained organic
phases were washed with a saturated sodium chloride solution, dried with anhydrous sodium sulfate
(Na2SO4 anh.), and the solvent removed under vacuum. The a-methylene-g-lactone crystallized out
from petrolether (yield of 730 mg, 56%).
IR (KBr): n(cm
-1
) 1765 (C=O, g-lact), 1705 (conj.), 1668, 1649 (C=CH2) (CO), 835 (=CH2),
800, 780 (CCl).
1
H-NMR (CDCl3,d): 1.35 (s, 3H, CH3), 3.95 (bd, H, C-3a, 3J=8.82 Hz, 4J=2.02 Hz,
4
J=3.03 Hz), 5.03 (d, H, C-7a,
3
J=8.82 Hz), 5.75 (dd. H, C-10 trans,
2
J=2.48 Hz,
4
J=3.03 Hz), 5.85
(s, 1H, CHCl2) 6.30 (dd, H, C-10 cis,
2
J=2.48 Hz,
4
J=2.02 Hz), 6.15 (d, H, C-5,
3
J=11.26 Hz), 6.51
(d, H, C-6
3
J=11.26 Hz).
13
C-NMR ppm: 171.7 (C-2), 126.7 (C-3), 24.5 (C-3a), 44.3 (C-4), 150.2
(C-5), 129.8 (C-6), 195.6 (C-7), 80.3 (C-7a), 18.9 (CH3), 78.8 (CHCl2), 137.33, (C-10). MS, M
+
,
260.000, m.p. 128130 ºC, yield 56%. Anal. calc. for C11H10O3Cl2(260.005): C, 50.77; H, 3.88.
Required: C, 50.25; H, 4.01.
Microorganisms
The strains Bacillus mycoides, Pseudomonas glicinea, Aspergillus niger, Agrobacterium tume-
faciens, Saccharomyces cerevisiae, and Pseudomonas fluorescens were from the collection of micro-
organisms of the Faculty of Science, Department of Biology, University of Kragujevac.
Fermentation. The A. niger and S. cerevisiae fungi were inoculated in a medium of the following
composition: peptone 1 (15.0 g), yeast extracts (5.0 g), dextrose (10.0 g), NaCl (10.0 g) and distilled water
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(1000 mL). A 1 mL suspension of the culture was put into 10-mL of aqueous substrate to which 2 mg
of lactone had been added (ca. 200 mg). This was incubated for five days at a temperature of 22 ºC.
The B. mycoides and A. tumefaciens bacteria were inoculated into a substrate consisting of a
mixture of peptone 1 greasy extract, NaCl, K2HPO4 total weight of 23.3 g dissolved in 1000 mL of
distilled water. The culture was obtained by adding 1 mL of medium suspension to 10 mL of substrate
containing 2 mg of the lactone (ca. 200 mg) and incubated for five days at a temperature of 22 ºC.
In the second series of the present investigation, in which the lactone served as a source of
organic carbon, amodified nutrient substrate was used. Hence,B. mycoides, A. tumefaciens, P. glicinea
andP. fluorescenswere cultivated on a mineral substrate of the following composition: agar-agar (20.0
g), KNO3 (2.0 g), MgSO4.7H2O (0.8 g), FeSO4.7H2O (0.1 g), NH4H2 PO4 (1.0 g), dissolved in 1000
mL of distilled water (pH 7.07.2).
The lactone was added to the nutrient substrate in two different concentrations. The first series
of samples had 1 mg of lactone in 10 mL of substrate (cca. 200 mg), whereas the second one had 7
mg of lactone in 10 mL of substrate (ca. 200 mg).
Determination of the products
Following the separation of mycelium, the sample, of 1000-mLvolume, was extracted with the
same volume of CH2Cl2 in order to identify the starting lactone, the number and the chemical structure
of transformed lactone products.
The extract thus obtained was dried with anhydrous Na2SO4, filtered, concentrated, and
analyzed by thin-layer chromatography (TLC) on silica-gel using hexane:acetone = 6:4 as the solvent.
The Rf values were determined relative to the standard, starting lactone.
The identification of the extracellular degradation products of the synthetic lactone was
performed by preparative TLC on silica gel, using hexane:acetone = 6:4 as the solvent system. The
spot fronts of the unkown compounds were marked by comparison wih a chromatogram obtained
under the same conditions when the spots were visible after developing the chromatogramwithH2SO4
or UV irradiation. The crude metabolic compounds were analyzed by IR.
13
C-and
1
H-NMR spectreo-
scopic analysis, and compared to literature data.
22
Compound (a):2-(4-dichloromethyl-6-hydroxy-4-methyl-2-cyclohex-2-en-1-one) acrylic acid.
Rf=0.36. IR (KBr), n(cm
-1
) 3450-2570 (OH), 1755 (C=O), 1705 (C=O conj.), 1668, 1649 (C=CH2),
1238, 1180 (CO), 855 (=CH2), 800, 780, (CCl).
1
H-NMR (CDCl3, d): 1.35 (s, 3H, CH3), 3.85 (bd,
H, C-5,
3
J=9.56 Hz), 5.03 (d, H, C-6,
3
J=9.56 Hz), 5.41 (bd, H, C-10,
2
J=1.75 Hz), 5.75 (bd, H, C-10,
2
J=1.75 Hz), 5.85 (s, 1H, CHCl2), 6.15 (d, H, C-2,
3
J=11.26 Hz), 6.51 (d,H, C-3,
3
J=11.26 Hz), 8.67
(bs. H, COOH).
13
C-NMR ppm: 166.7 (C=O, C-11), 145.7 (C-9), 120.2 (C-10), 35.57 (C-5), 46.38
(C-4), 148.29 (C-3), 129.8 (C-2), 195.6 (C-1), 77.6 (C-6), 18.98 (C-8), 79.76 (C-7). m.p. 155157 ºC,
yield. 42 mg. 19.7%. Anal. calc. for C11H12O4Cl2(278.0114): C, 47.33; H, 4.35. Required: C, 47.84;
H, 4.21.
Compound (b): 2-(6-hydroxy-4-methyl-2-cyclohex-2-en-1-one) acrylic acid. Rf=0.17. IR (KBr),
n(cm
-1
)34502570 (OH), 1765 (C=O), 1705 (C=O, conj.), 1668, 1649, (C=CH2), 1180 (CO), 845 (=CH2).
1
H-NMR (CDCl3, d): 1.23 (d, 3H, CH3,3J=9.2 Hz), 2.05 (m, H, C-4, 3J=9.2 Hz), 3.34 (m, H, C-5, 3J=8.75
Hz), 5.09 (d, H, C-6.
3
J=8.75 Hz), 5.37 (bd, H, C-9,
2
J=1.7 Hz), 5.73 (bd, H, C-9,
2
J=1.7 Hz), 6.15 (d, H,
C-5,
3
J=10.33Hz), 6.51 (d,H, C-6,
3
J=10.33Hz), 8.61 (bs,H. COOH).
13
C-NMR, ppm: 168.3 (C=O,C-10),
149.6 (C-8), 123.8 (C-9), 36.67 (C-5), 40.72 (C-4), 149.19 (C-3), 127.6 (C-2), 194.4 (C-1), 74.2 (C-6), 16.8
(C-7), oil, yield, 32 mg. 21%. Anal. calc. for C10H12O4; (196.0735); C, 61.20; H, 6.17. Required: C, 61.78;
H, 6.21.
Compound (c): 10-methyl-4-methyliden-5-hydroxy-perhydroisochrom-7-en-3,6-dione: Rf=0.44.
IR (KBr), n(cm
-1
): 3560-3360 (OH), 1740 (C=O, d-lact), 1705 (C=O, conj.), 1685 1649 (C=CH2), 1250
(CO), 855 (=CH2).
1
H-NMR (CDCl3,d): 1.25 (s, 3H,CH3), 4.15 (ABq., 2H,Dn=32.6Hz), 5.23 (d,H,C-5,
3
J=7.9Hz), 2.90 (bd,H,C-9,
3
J=7.9 Hz,
4
J=0.8 Hz), 5.14 (bd. H,C-10,
2
J=1.75 Hz,
4
J=0.6 Hz), 5.72 (bd,H,
C-10,
2
J=1.75Hz,
4
J=0.8Hz), 6.15, (d,H,C-5,
3
J= 11.2Hz) 6.51 (d,H,C-6,
3
J=11.2Hz).
13
C-NMR (ppm):
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167.7 (C=O,C-3), 149.3 (C-4), 110.2 (C-11), 33.47 (C-9), 36.38 (C-10), 150.23 (C-8), 129.0 (C-7),
196.54 (C-6), 73.31 (C-5), 14.38CH3.M.p. 139141 ºC, yield, 36mg, 22.7%.Anal. calc. for C11H10O4
(206.0579): C, 64.06; H, 4.89. Required: C, 64.67; H, 4.25.
Compound (d): 2-(4-dimethyl-6-hydroxy-2-cyclohex-2-en-1-one)acrylic acid Rf = 0.09. IR
(film), n(cm
-1
): 3450-2570 (OH), 1755 (C=O), 1705 (C=O conj.), 1668, 1649 (C=CH2), 1170 (CO),
845 (=CH2).
1
H-NMR (CDCl3,d): 1.23 (s, 2H, CH3), 1.34 (s, 3H, CH3), 3.21 (m,H, C-5, 3J=9.25 Hz),
5.19 (d, H, C-6,
3
J=9.25 Hz), 5.37 (bd. H, C-9,
2
J=1.8 Hz), 5.69 (bd, H, C-9,
2
J=1.8 Hz), 6.10 (d, H,
C-5,
3
J=10.75Hz), 6.28 (d, H, C-6,
3
J=10.75 Hz). Oil, yield 19 mg, 11.8%. C11H14O4: MS, M
+
(210.089) 11, 192 (M
+
18) 21, 195 (M
+
15) 14, 177 (M
+
1815) 24.
I Z V O D
MIKROBIOLO[KA TRANSFORMACIJA SINTETI^KOG LAKTONA
BENZOFURANSKOG TIPA
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Ciq ovog rada je ispitivawe mogu}nosti biotransformacije benzofuranskog
derivata, sa a-metilen-g-butirolaktonskom strukturnom jedinicom, sa razli~itim so-
jevima mikroorganizama: Aspergillus niger, Saccharomyces cerrevisiae, Bacillus mycoides, Agro-
bacterium tumefaciens, Pseudomonas glicineaiPseudomonas fluorescens u ciqudobivawanovih
jediwewa sa specifi~nijom antimikrobnom aktivno{}u. Tako|e izolovani i identi-
fikovani proizvodi su ukazali i potvrdili osnovne biodegradacione puteve ispiti-
vanog laktona.
(Primqeno 22. februara 1999)
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